HCA
MRTX

Harbor Capital Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Harbor Capital Advisors’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-676
Closed -$24.4K – 668
2023
Q2 		$24.4K Buy
+676
New +$24.4K ﹤0.01% 562